Systemic Capillary Leak Syndrome (SCLS): A Patient Guide

Emergency Disclaimer: Suspected SCLS is a medical emergency. If you experience rapidly increasing swelling, severe dizziness, new shortness of breath, or markedly reduced urine, call your local emergency services immediately. Do not attempt to manage a suspected attack at home, and do not use this guide to self-limit fluids or delay treatment.

Systemic Capillary Leak Syndrome (SCLS), also known as Clarkson’s disease, is an exceptionally rare condition characterized by sudden, temporary episodes where the walls of the smallest blood vessels—the capillaries—become porous. During these flares, the liquid portion of the blood (plasma) and essential proteins leak out of the circulatory system and into the surrounding tissues. This process leads to a “classic triad” of physiological changes: a dangerous drop in blood pressure (hypotension), a significant drop in blood protein levels (hypoalbuminemia), and a thickening of the remaining blood as the red blood cells become highly concentrated (hemoconcentration) ^[1][2].

An SCLS attack typically unfolds in three phases, varying by person, beginning with a prodromal phase where you may feel generally unwell with flu-like symptoms, fatigue, or dizziness. This is followed by the leak phase, a critical period where the loss of blood volume can lead to visible swelling, rapid weight gain, and circulatory shock. Finally, the body enters the recovery phase, during which the capillaries regain their integrity and the leaked fluid is reabsorbed back into the bloodstream ^[3][4]. Because the transition between these phases involves massive shifts of fluid, specialized medical monitoring is essential throughout the entire cycle ^[5].

The management of an acute SCLS flare requires a unique, highly individualized medical approach. While most patients in shock receive large amounts of intravenous fluids, doing so without careful monitoring during an SCLS leak can worsen tissue swelling and lead to serious complications in the limbs or lungs. Instead, expert care focuses on a cautious, hemodynamic-guided fluid strategy and the early use of medications to support blood pressure, ensuring that the body is supported through the crisis without being overloaded by excess volume ^[6][7].

Although the rarity and intensity of SCLS can be daunting, the focus of modern care has shifted toward long-term stability and the prevention of future attacks. For many patients with primary/idiopathic SCLS, the use of regular preventative treatments, such as Intravenous Immunoglobulin (IVIG), has fundamentally changed the nature of the condition. While these therapies are preventive and do not cure the underlying condition, they help stabilize the vascular system, significantly reducing the frequency of flares. Navigating SCLS is about moving from the uncertainty of a rare diagnosis toward a structured partnership with a specialized care team ^[8][9].